Johnson & Johnson (JNJ) Tops Q1 EPS by 6c

(Updated - April 16, 2019 6:43 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.10, $0.06 better than the analyst estimate of $2.04. Revenue for the quarter came in at $20.02 billion versus the consensus estimate of $19.61 billion.

GUIDANCE:

Johnson & Johnson sees FY2019 EPS of $8.53-$8.63, versus the consensus of $8.58. Johnson & Johnson sees FY2019 revenue of $80.4-81.2 billion, versus the consensus of $81.05 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15